News

CRISPR gene therapy shows improved haemoglobin levels and reduced vaso occlusive events in severe sickle cell disease in early phase study data.

COVID-19 disrupted melanoma diagnoses, reducing early detection and shifting prognostic patterns across regions with different public health strategies.

Large phase 3 trial involving over 300 patients with active lupus, those treated with obinutuzumab achieved markedly higher response rates at one year. Nearly 77% of patients receiving the therapy met the primary endpoint

Discover how new findings in endometriosis genetics could transform diagnosis and treatment.

Large cohort study finds increased cognitive impairment risk in rheumatoid arthritis, supporting routine cognitive screening in clinical care.

ADHD symptoms are linked to chronic pain severity, with emotional factors influencing outcomes in patients resistant to standard care.

Australian cohort study has found that HIV incidence among transgender people fell by almost 94% between 2014 and 2023.

Results showed that the POST group achieved a statistically significant reduction in CSMS compared with placebo (p=0.022), with an average improvement 0.6 points greater than control.